Question-and-Answer Session
Operator
(Operator instructions) And your first question comes from the line of Quintin Laid with Robert W. Baird. You may proceed.
Quintin Lai - Robert W. Baird & Co., Inc.
Hi, good afternoon. As you were looking through the performance in the fourth quarter, was it a steady deterioration and could you give us a little color about , now that we’re a few weeks into January, what you’re seeing now and is that what’s giving you the few weeks of visibility that you have right now?
Robert F. Friel
Quintin, this is Rob. I would say it really varies by business, because we are operating in a couple of different end markets. It would be tough to characterize everything about the same. I would say probably in the Analytical Sciences’ end market, it was probably more gradual as the quarter went along. I would say, in probably medical imaging, it was more dramatic of a drop-off. As we mentioned service hasn’t really seen much of an impact from this. BioDiscovery, as Mike mentioned have a good quarter, and I would say probably on the Illumination and Detection side, it was probably more gradual. So it depends a little bit on what end markets and business you’re talking about.
Quintin Lai - Robert W. Baird & Co., Inc.
As you look at the range of expectations that you said for organic revenue growth, Rob, do you think that you captured some of a bad case scenario? I know you can’t say worst case scenario, but –
Robert F. Friel
So, I would say right now, we think it’s realistic and I would say we’re not assuming any recovery in the back half of the year. I would say we’ve assumed in this forecast that economic conditions don’t change, meaning they don’t get any better, but I would say they don’t get significantly worse. And of course we provide ourselves, I think enough range around that, that gives us some latitude that things could maybe deteriorate a little bit, but not I would say a significant downturn. So, I think it’s fairly realistic and we try to put some ranges around that will give us latitude to see a little bit of softness, but not I would say a significant change from where we are right now.
Quintin Lai - Robert W. Baird & Co., Inc.
With respect to your operating expenses and you’re trying to mention the cost controls, are there any other leverage that you have at your disposal in the event that things get a little tougher or how should we think about - ?
- To read the full transcript on Seeking Alpha, click here »
